Are we victims of our own success in cardiovascular therapeutics?
Publication
, Journal Article
Farzaneh-Far, A; Libby, P
Published in: Curr Atheroscler Rep
January 2007
Duke Scholars
Published In
Curr Atheroscler Rep
DOI
ISSN
1523-3804
Publication Date
January 2007
Volume
9
Issue
1
Start / End Page
1 / 2
Location
United States
Related Subject Headings
- Research Design
- Randomized Controlled Trials as Topic
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Biomarkers
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Farzaneh-Far, A., & Libby, P. (2007). Are we victims of our own success in cardiovascular therapeutics? Curr Atheroscler Rep, 9(1), 1–2. https://doi.org/10.1007/BF02693929
Farzaneh-Far, Afshin, and Peter Libby. “Are we victims of our own success in cardiovascular therapeutics?” Curr Atheroscler Rep 9, no. 1 (January 2007): 1–2. https://doi.org/10.1007/BF02693929.
Farzaneh-Far A, Libby P. Are we victims of our own success in cardiovascular therapeutics? Curr Atheroscler Rep. 2007 Jan;9(1):1–2.
Farzaneh-Far, Afshin, and Peter Libby. “Are we victims of our own success in cardiovascular therapeutics?” Curr Atheroscler Rep, vol. 9, no. 1, Jan. 2007, pp. 1–2. Pubmed, doi:10.1007/BF02693929.
Farzaneh-Far A, Libby P. Are we victims of our own success in cardiovascular therapeutics? Curr Atheroscler Rep. 2007 Jan;9(1):1–2.
Published In
Curr Atheroscler Rep
DOI
ISSN
1523-3804
Publication Date
January 2007
Volume
9
Issue
1
Start / End Page
1 / 2
Location
United States
Related Subject Headings
- Research Design
- Randomized Controlled Trials as Topic
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Biomarkers
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology